Director, Portfolio Insights

Company Description

About Abb Vie

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on Linked In, Facebook, Instagram, X and You Tube.

The Portfolio Insights team is responsible for enabling Abb Vie to make data-driven decisions on portfolio choices both within and across Therapeutic Areas (TAs). Core responsibilities include valuation of the internal portfolio, PTRS (probability of technical and regulatory success) assessments, cross-TA prioritization of R&D spend, benchmarking and analytic support for annual financial business processes.

The Director, Portfolio Insights drives high-impact strategic projects and provides broad exposure across Portfolio Insights’ core capabilities. Success will position the Director to transition into a longer-term focus area within Portfolio Insights based on strengths and business needs; options include:

• TA strategic partner: Drive value metrics and PTRS insights for one or more therapeutic areas in partnership with TA leadership.
• Cross-TA prioritization: Support prioritization and capital allocation analytics (e.g., Quarterly Portfolio Prioritization process enhancements), helping ensure R&D investment is directed toward the highest-value opportunities.
• Data strategy and benchmarking insights: Advance the R&D productivity benchmarking agenda (e.g., peer comparisons) and translate findings into actionable insights for decision-makers.

• Strategic initiative leadership: Drive high-priority 2026 strategic initiatives, including but not limited to:
  • Continue to enhance the Quarterly Portfolio Prioritization (QPP) process to improve Abb Vie’s ability to effectively allocate capital to the areas of greatest value creation.
  • Pull-through ongoing modernization of Abb Vie’s valuation methodologies to best-in-class assessment approaches – including AI/ML driven PTRS assessment.
  • Institute R&D productivity as a core organizational mindset by collaborating on the “R&D Pulse” initiative and benchmarking Abb Vie’s performance versus peers.
• Cross-functional agility: Flex into different areas of the portfolio to conduct ad-hoc, short-term analyses, scenario planning, and strategic projects at the request of leadership.
• Executive narrative development: Deliver high-impact recommendations on project value, trade-offs, and scenarios to senior leadership. Prepare actionable insights and executive narratives for the monthly Portfolio Review Forum, R&D Plan, and Financial Long Range Planning (LRP).
• Change management & capability building: Socialize the value and practical implications of moving to a more data-driven approach for key decision-making across TA leadership. Build capabilities within the team and across the organization.
• Value assessment & analytics: Build value metrics (e.g., risk-adjusted net present value (raNPV), Productivity Index) and scenario analyses to drive effective drug development decisions. Constructively pressure-test assumptions and inputs provided by functional stakeholders (e.g., Finance, PPM).
• Democratization of data: Support efforts to deploy and improve dashboards for interrogating the R&D portfolio, exploring new use cases that leverage Abb Vie’s foundational portfolio data.

• Bachelor’s degree in a scientific or business field required; advanced degree (e.g., Pharm
  
  D, PhD, MD, MBA) highly preferred.
• Prior experience in management consulting, with a track record in R&D strategy / portfolio prioritization projects, strongly preferred.
• Preferred years of experience: 8+ with a Bachelor’s, 6+ with a Master’s, or 4+ with a Doctorate.
• Exceptional analytical and problem-solving skills, with a deep understanding of Pharma R&D business processes, investment stage-gating, and commercial forecasting.
• Demonstrated success in fast‑paced,…